2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Congestive Ophthalmopathy in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XL | 1 |
| He, WM | 1 |
| Li, W | 1 |
| Zhang, L | 1 |
| Grennan-Jones, F | 1 |
| Draman, MS | 1 |
| Lane, C | 1 |
| Morris, D | 1 |
| Dayan, CM | 1 |
| Tee, AR | 1 |
| Ludgate, M | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Congestive Ophthalmopathy
| Article | Year |
|---|---|
[Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].
Topics: Cells, Cultured; Chromones; Fibroblasts; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Morpholines | 2017 |
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
Topics: Adipogenesis; Cells, Cultured; Chromones; Drug Discovery; Gene Expression Regulation; Graves Ophthal | 2014 |